AB
Avenue Biosciences Holding Inc
SEC filingBiotechnology · Menlo Park, CA
Amount raised$7.4Msold at filing
Total offering$8.4M$917K still open
Investors in the raise12count reported to the SEC
FiledJan 28, 2026first sale Nov 20, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jenny EngerfeltDirector
Gabriel PoteliunaiteDirector
Katja RostiExecutive Officer, Director
Tero-Pekka AlastaloExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.